πŸ‡ΊπŸ‡Έ FDA
Patent

US 11497752

Compounds and uses thereof

granted A61KA61K31/427A61K31/4409

Quick answer

US patent 11497752 (Compounds and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/427, A61K31/4409, A61K31/4425, A61K31/4439